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Background: Previous publications have stressed the benefits of mitral valve 
repair over mitral valve replacement in children. However, few communi- 
cations have reported the long-term results and none with a follow-up of 
more than 10 years. This article reports our results in a series of 145 
patients operated on for congenital mitral valve insufficiency by means of 
the same technique (Carpentier's technique) in a single center. Methods: 
Between 1970 and 1995, 145 patients younger than 12 years old underwent 
surgery for congenital mitral valve insufficiency. Mean age was 5.7 --+ 3.1 
years, ranging from 0.17 to 12 years. Mitrai valve insufficiency associated 
with atrioventricular defect, atrioventricular discordance, straddling mitral 
valve, acquired diseases, Marfan syndrome, and degenerative disease was 
excluded from this study. According to Carpentier classification, 31 pa- 
tients had type I mitral valve disease (normal leaflet motion), 79 patients 
type II (leaflet prolapse), and 35 type I I I  (restricted leaflet motion), with 15 
having normal papillary muscles and 20 abnormal papillary muscles. 
Associated lesions were present in 51 patients (35%). A conservative 
operation was possible in 138 patients (95%). Among them, 70 patients 
required a prosthetic annuloplasty and 21 patients valve extension with a 
pericardial patch. Valve replacement was necessary in seven patients (5%). 
Results: In-hospital mortality was 5% (95% CL: 2.5% to 9.9%) (seven 
patients). No early death was observed in the group of patients who 
underwent valvular replacement. In-hospital mortality was as follows: type 
I, 9.6%; type II, 2.5%; and type III, 13%. No statistically significant 
difference was noted among patients with the different types of disease. 
Mean follow-up was 9.3 - 6.9 years (1 to 26 years), and cumulative 
follow-up was 1142 patient-years. Ten late deaths occurred. Actuarial 
survival at 10 years was 88% in patients who underwent valve repair and 
51% in patients who underwent valve replacement. Late reoperation was 
required in 15% (n = 21) of patients who had undergone valve repair and 
28% (n = 2) in patients with valve replacement. Causes of reoperation were 
recurrent left ventricular failure (n = 1), residual or recurrent mitral valve 
insufficiency (n = 17), mitral valve steuosis (n = 3), and calcification of the 
bioprosthesis (n = 2). No failure resulting from leaflet extension was 
observed. In the repair group, actuarial freedom from reoperation was 68% 
(95% CL: 80.5% to 51.5%) at 15 years, and the linearized rate of exposure 
to reoperation was 1.9% per patient-year. No thromboembo|ic event was 
observed in any group. Conclusion: Congenital mitral valve insufficiency can 
be repaired in infancy with a low mortality. Conservative surgery with 
Carpentier's techniques is feasible in the majority of cases of congenital 
mitral valve insufficiency. This technique offers stable long-term results 
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with a low rate of reoperation. Leaflet extension associated with prosthetic 
ring annuloplasty could prevent reoperations in selected cases. (J Thorac 
Cardiovasc Surg 1998;115:84-93) 
S ince the original publ icat ion by Carpent ier  and associates t in 1976 on the surgical correct ion of 
congenital  mitral  valve insufficiency (MVI) ,  several 
authors have reported their own experience. 2'3 
These reports concluded that conservative surgery 
initially provides good results but that the rates of 
reoperat ion were h igh)  The aim of this study is to 
report  our own experience with the same technique 
and with results extending over 10 years. 
Patients and methods 
From November 1970 to October 1995, 145 patients 
less than 12 years of age were operated on for congenital 
MVI in our institution. MVI associated with atrioventric- 
ular (AV) defect, AV discordance, straddling mitral valve, 
and acquired valvular diseases were excluded from this 
study. Those with Marfan's syndrome and other degener- 
ative diseases were also excluded. The series comprised 74 
boys and 71 girls whose ages ranged from 2 months to 12 
years (mean 5.7 -+ 3.1 years and 0.17 to 12 years, 
respectively). At the time of the operation, 47 patients 
(32.2%) were in New York Heart Association class II, 73 
(50.7%) in class III, and 25 (17.1%) in class IV. The mean 
cardiothoracic ratio was 0.64 _+ 0.08, ranging from 0.8 to 
0.4. All but three children (2%) were in sinus rhythm. The 
degree of MVI, left ventricular function, and associated 
anomalies were assessed by echocardiography or cardiac 
catheterization, or by both methods. MVI was grade 3/4 or 
4/4 in all patients. 
Classification of mitral valve anomalies (Table I). The 
mitral valve malformations were classified according to 
Carpentier's functional classification. 4 Because several 
anomalies may coexist, the predominant one was used to 
classify the malformation. The distribution of children 
according to this classifcation is shown in Table I. 
Type I: Mitral valve incompetence with normal leaflet 
motion (n = 31). Three malformations belong to this 
group: 
1. ANULUS DILATATION (N = 7). The circumference of
the anulus was 20% to 50% greater than that set forth in 
the table developed by Rowlatt, Rimoldi, and Lev. s The 
dilatation affected mainly the posterior aspect of the 
anulus. It was usually associated with minor anomalies 
such as imperforate interchordal spaces demonstrating 
the congenital origin of the dilatation. 
2. CLEFT LEAFLET (N = 18). In this group the cleft most 
frequently involved the anterior leaflet. The cleft was 
either complete or partial, with no other anomaly of the 
mitral valve, which is in contrast o the AV septal defect 
valve. 
3. LEAFLET DEFECr (N = 6). The leaflet defect anomaly 
consists of a partial agenesis of the posterior leaflet, with 
absence of chordae to the corresponding free edge. 
Table I. Classification of  the mitral valve lesions 
according to the Carpentier functional approach 
Type n % of 145 
Type I: Normal eaflet motion 31 21.4 
1. Annular dilatation 7 4.8 
2. Cleft leaflet 18 1.2 
3. Leaflet defect 6 4.1 
Type II: Leaflet prolapse 79 54.5 
1. Chordal elongation 46 31.7 
2. Papillary muscle elongation 24 16.5 
3. Absence of chordae 9 6.2 
Type III: Restricted leaflet motion 35 24.1 
A: Normal papillaary muscles 15 
1. Commissure papillary fusion 8 5.5 
2. Short chordae 7 4.8 
B: Abnormal papillary muscles 20 
1. Parachute mitral valve 5 3.4 
2. Hammock mitral valve 12 8.2 
3. Papillary muscle hypoplasia 3 2 
Type II: Leaflet prolapse (n = 79). The prolapse of the 
free edge of one or two leaflets within the left atrium 
could be due to several malformations. 
1. Chordal elongation (n = 46), often involving all of the 
chordae tendineae arising from one papillary muscle 
2. Papillary muscle elongation (n = 24) 
3. Absence of chordae tendineae (n = 9) 
Type IlI: Restricted leaflet motion (n = 35). The group 
with restricted leaflet motion comprised two subgroups 
depending on the structure of the papillary muscles: 
NORMAL FAFILLAR¥ MUSCLES (N = 15). In this subgroup 
two papillary muscles were individualized on echocardi- 
ography. 
1. COMMISSURE PAPILLARY MUSCLE FUSION (N = 8). The 
papillary muscles were adherent to the commissure, which 
were fused. The fusion often was bilateral. 
2. SHORT CHORDAE (N = 7). All the involved chordae 
could be short or limited to the chordae of one leaflet. 
ABNORMAL PAPILLARY MUSCLE 0V = 20). In this sub- 
group the papillary muscles were abnormal in number or 
position or both. 
1. PARACHUTE MITRAL VALVE (N = 5). In this malforma- 
tion, the chordae arose from one papillary muscle im- 
planted on the inferior third of the left ventricle. The 
cause of regurgitation was a lack of valvular tissue, short 
chordae, annular dilatation, or a combination of these 
malformations. 
2. HAMMOCK MITRAL VALVE (N = 12). The term ham- 
mock mitral valve defines an anomaly of the papillary 
muscles displaced upward and posteriorly under the mural 
leaflet. Subsequently, the chordae of the anterior leaflet 
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Fig. 1. Cleft leaflet closed with a pericardial patch. 
Table II. Coexisting cardiac anomalies (51 patients) 
Associated lesions n 
ASD 13 
VSD 12 
Coarctation of the aorta 6 
Patent ductus 5 
Constrictive pericarditis 3 
Subaortic stenosis 3 
TI 3 
Aortic arch anomaly 1 
AI 1 
AS 1 
Coronary artery fistulas 1 
Pulmonary artery stenosis 1 
TGA l 
AI, Aortic valve insufficiency; AS, aortic valve stenosis; ASD, atrial septal 
defect; TGA, Transposition f the great arteries; TI, tricuspid valve 
insufficiency; VSD, ventricular septal defect. 
cross the mitral valve orifice, producing partial obstruction 
at very the least. 
3. PAPILLARY MUSCLE HYPOPLASIA (N = 3). The anterior 
papillary muscle was the muscle most often involved with 
hypoplasia. This anomaly was associated with hypoplasia 
of the corresponding commissure and adjacent anterior 
leaflet issue with a "cleft commissure" aspect. In this type 
IIi group, mitral valve stenosis was associated when a 
commissure papillary muscle fusion, a parachute valve, or 
a hammock valve was present. 
Associated lesions. Associated lesions, listed in Table 
II, were present in 51 patients (35%). Five had undergone 
previous repair of associated lesions: aortic coarctation 
(n = 3), closure of ventricular septal defect (n = 1), and 
transposition of the great arteries (n = 1). 
Operative techniques. Standard hypothermic (28 ° C) 
cardiopulmonary b pass with bicaval cannulation was 
performed in all patients. A cold blood cardioplegic 
solution was used for myocardial protection with topical 
cold saline solution i fused into the pericardium. The 
Fig. 2. Hammock mitral valve. Posterior leaflet extension 
with pericardial patch, 
Table I l l .  List o f  the different conservative 
techniques in 138 patients who underwent mitral 
valve repair 
Procedures' n % of 138 
Annuloplasty 
Carpentier prosthetic ring 70 48 
Plication of the commissures 6 4 
Plication of the anulus 5 3 
Semicircular suture 5 3 
Cleft suture without patch 14 10 
Pericardial patch enlargement 
Anterior leaflet 14 10 
Posterior leaflet 8 5 
Chordal shortening 46 33 
Papillary muscle shortening 24 17 
Chordal transposition 12 8 
Commissurotomy 15 10 
Splitting of papillary muslce 13 9 
Fenestration of papillary muscle 9 6 
mitral valve was approached through theleft atrial wall 
after dissection of the AV groove. The mitral valve 
apparatus was analyzed to confirm the functional c ass and 
to allow the surgeon to decide the appropriate type of 
repair. 
Mitral valve repair. A conservative operation, per- 
formed with the use of techniques previously described by 
Carpentier,1.4. 6 was possible in 138 patients (95%). A list 
of the procedures i  detailed in Table III. Inasmuch as the 
malformation usually implies several anomalies, several 
techniques were used in the same patient. Annular dila- 
tation and deformation was present as a single anomaly in 
patients with type I MVI, as an associated anomaly in 
most patients with type II, and in some patients with type 
III MVI. 
Annular deformation was treated by remodeling with a 
Carpentier-Edwards prosthetic ring (Baxter Healthcare 
Corp., Edwards Division, Santa Ana, Calif.) in 70 patients 
(48%). Ring sizes ranged from 20 to 34 mm (mean 27 mm). 
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Fig. 3. Actuarial survival of children undergoing mitral valve repair or replacement. 
Attempts to avoid the use of a prosthetic ring in very 
young children led to the use of several annuloplasty 
techniques in 16 patients (12%). These techniques in- 
cluded commissural plication, anulus plication after par- 
tial resection of the posterior leaflet, and semicircular 
annuloplasty. The valve was enlarged with an autologous 
pericardial patch 7in nine patients to allow use of a larger 
prosthetic ring and to avoid progressive mitral stenosis 
during the child's natural growth. The enlargement in- 
volved the anterior leaflet in three children and the 
posterior leaflet in six. 
Cleft leaflet was corrected either by a direct suture 
technique or with an autologous pericardial patch when a 
large leaflet issue defect was present (n = 4) (Fig. 1). In 
these cases preliminary extensive leaflet mobilization was 
achieved by resecting all the chordae inserted on the cleft 
or on the adjacent leaflet issue. 
A posterior leaflet defect was corrected by plication of 
the anulus at the site of the defect associated with a sliding 
plasty. An anterior leaflet defect was treated by an autol- 
ogous pericardial patch (n - 3) associated with chordal 
transposition. 
Prolapse of a leaflet was corrected by means of the 
techniques previously described. 1' 4, 6 Chordal elongation 
of the anterior leaflet was treated either by a sliding plasty 
of the papillary muscle or by chordal shortening. 
Chordal elongation of the posterior leaflet was treated 
by quadrangular resection of the corresponding prolapsed 
area. Papillary muscle elongation was treated by partial 
resection or plication of the tip of the papillary muscle. 
Absence of chordae was treated by chordal transposition 
of the anterior leaflet or by leaflet resection of the 
posterior leaflet. In cases of commissure papillary muscle 
fusion, bilateral commissurotomy and deep splitting of the 
papillary muscles were performed. 
Table IV. Hospital mortality 
Age Associated 
No. (yr) MV lesions anomaly Cause of death 
1 4 Cleft 0 Tracheal inhalation 
2 0.8 Commissural 0 LV failure 
papillary 
muscle fusion 
3 7 Prolapse VSD Pulmonary artery 
hypertension 
4 5 Hammock 0 LV failure 
5 4 Prolapse 0 LV failure 
6 4 Cleft VSD Pulmonary artery 
hypertension 
7 1 Anulus 0 Dilatcd cardiomyopathy, 
dilatation LV failure 
LV, Left ventricle; VSD, ventricular septal defect. 
Short chordae were treated by multiple splitting of the 
tip of the corresponding papillary muscle. The parachute 
mitral valve was corrected by splitting the papillary muscle 
and fenestration of the interchordal spaces. The hammock 
valve was treated by partial resection or splitting of the 
muscular mass underneath the posterior leaflet. In four 
patients it was necessary to detach the posterior leaflet 
and perform subsequent patch enlargement (Fig. 2). 
Papillary muscle hypoplasia ssociated with leaflet hypo- 
plasia was treated either by plication of the anulus to 
reconstruct the commissural rea (n = 1) or by enlarge- 
ment of the leaflet tissue with an autologous pericardial 
patch (n = 2). 
At the end of the procedure a baseline test was per- 
formed with injection of saline solution within the left 
ventricle. Transesophageal echocardiography was used 
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Fig. 4. Actuarial freedom from reoperation after mitral valve repair. 
Table V. Causes of late death 
Age at 
operation Functional Associated Early Delay 
No. (yr) tyl)e lesion result (yr) Cause of death 
Repair 
1 1.5 Prolapse 0 Good 5 Unknown 
2 2 Short chordae 0 Poor 1 LV failure 
3 7 Prolapse 0 Good 9.8 Recurrent MVI, no reoperation 
4 9 Prolapse 0 Good 8.6 Recurrent MVI, no reoperation 
5 4.5 Prolapse 0 Good 7.9 Recurrent MVI, no reoperation 
6 3 Prolapse 0 Good 2 LV failure 
Replacement 
1 3 Prolapse 0 Good 3.6 Unknown 
2 1.6 Prolapse AVS Poor 2.5 LV dilatation 
3 4.5 Hammock 0 Poor 3.8 Restrictive cardiomyopathy 
AVS, Aortic valve stenosis; LV, left ventricle; MV/, mitral valve insulficiency. 
only in children weighing more than 20 kg. Most patients 
had continuous monitoring of left atrial pressure for 24 
hours. 
Valvular eplacement. A valvular eplacement was nec- 
essary in seven patients (5%): for parachute mitral valve 
(n = 1), hammock valve (n = 1), commissure papillary 
muscle fusion (n = 1), leaflet prolapse (n = 3), and short 
chordae (n = 1). Five bioprosthetic valves and two 
mechanical vanes were implanted. Bioprosthetic valves 
were not used after 1985, when data on early degeneration 
were well established. 
Associated lesions. Associated lesions were corrected 
during the same procedure in 43 patients. Coarctation of 
the aorta was repaired by an end-to-end anastomosis 
through the anterior approach during the mitral valve 
operation. In two patients delayed repair of the coarcta- 
tion was performed. The aortic arch anomaly was not 
treated because no clinical syrhptom was present. 
Results 
Statistical analysis. Data are expressed as 
mean _+ one standard deviation. The postoperative 
events, survival, and reoperation rates were ob- 
tained by the Kaplan-Meier actuarial method. 
Hospital mortality. Seven patients died (5%) 
(95% confidence limits [CL]: 2.5% to 9.9%) in the 
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Fig. 5. Restricted leaflet motion resulting from short chordae, associated with annular dilatation. 
Pericardial patch enlargement and prosthetic ing (A) compared with semicircular plication (B). 
repair group (Table IV). The mean age of children 
who died during the operation was 3.7 _+ 2.1 years. 
Two deaths were due to persistent pulmonary artery 
hypertension after closure of a ventricular septal 
defect. Mortality was 9.6% (3/31) in type I, 2.5% 
(2/79) in type II, and 13% (2/15) in type III. No 
statistically significant correlation was apparent be- 
tween hospital mortality and functional type. 
Follow-up. This study followed the recommenda- 
tions of the Ad Hoc Liaison Committee on "Guide- 
lines for Reporting Morbidity and Mortality After 
Cardiac Valvular Operations. ''s All information was 
obtained from June 1996 to January 1997 through 
consultations and questionnaires sent to the patients 
and to their referring physicians. Ten patients 
(6.8%) were lost to follow-up after hospital dis- 
charge. The average follow-up was 9.3 + 6.8 years (1 
to 26.2 years), and the cumulative follow-up was 
1142 patient-years. The theoretical follow-up would 
have been 1331 patient-years if complete. 
Long-term survival. Late deaths occurred in six 
of 138 patients (4%) after repair and in three of 
seven patients (43%) after replacement (Table V). 
Three patients living abroad had recurrence of MVI 
and could not be reoperated on. The 10-year sur- 
vival was 86% (95% CL: 77.4% to 91.3%) for the 
entire cohort, 88% (95% CL: 79.8% to 93%) for the 
repair group and 51% (95% CL: 19.7% to 82.1%) 
for the valve replacement group. At 15 years the 
survival of the repair group was 88% (95% CL: 
79.8% to 93%) (Fig. 3). 
Functional status. After repair 85% of patients 
were in New York Heart Association class I, 4.8% in 
class II, 4.8% in class III, and 6% in class IV, 
excluding patients reoperated on for mitral valve 
dysfunction. After valve replacement only two pa- 
tients (28%) survived; they were doing well 4 and 13 
years after the operation. No thromboembolic or
hemorrhagic episodes occurred in any group. 
Reoperation 
Repair group. Twenty-one patients (15%) re- 
quired a reoperation 24 hours to 21 years (mean 5.8 
years) after the initial repair (Table VI). The actu- 
arial reoperation rate was 1.9% per patient-year. 
Actuarial freedom from reoperation was 95.5% 
(95% CL: 97.8% to 90.2%) at 1 year, 86% (95% CL: 
91.4% to 78%) at 5 years, 80% (95% CL: 87.25% to 
70.8%) at 10 years, and 67.7% (95% CL: 80.4% to 
51.7%) at 15 years (Fig. 4). The causes of reopera- 
tion are as follows: Congestive dilatation f the 
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Table VI. Reoperation in the repair group 
Age Prosthetic Causes of 
No. (yr) Type ring reop. Delay Treatrnent 
1 6 11 0 LV failure 17.7 yr Cardiomyoplasty 
2 11 I1 32 MVI 10.4 yr BP and MVP 
3 9 I 1 0 MVI 2.9 yr BP and MVP 
4 6 12 26 MVI 1 yr MVP 
5 3 II 1 26 MVS 6.5 yr Conservative 
6 1 II 1 0 MVI 4.5 yr MVP 
7 4 II 1 0 MVI 1 yr Prosthetic ring 
8 5 IIj 0 MVI 0.5 yr Prosthetic ring 
9 12 II 2 30 MVI 12 yr Conservative 
10 8 II 2 32 MVI 7.1 yr MVP 
11 4 II 2 24 MVI 6 days Conservative 
12 5 II 2 0 MVI 3.5 yr Prosthetic ring and MVP 
13 4.5 II~ 26 MVI 0.6 yr MVP 
14 5 II 3 0 Endocarditis 21 yr MVP 
15 7 I l iA  26 MV$ 4 yr Conservative 
16 0.8 IIIA1 0 MVI 7 days Conservative, death 
17 2 I I IA 2 0 MVS 14.2 yr MVP 
18 12 II IA 2 0 MVI 6.5 yr MVP 
19 0.5 IIIBz 0 MVI 1 days Conservative 
20 2.5 IIIB 2 0 MVI 10 days Prosthetic ring 
21 5 IIIB 2 0 MVI 7.3 yr Prosthetic ring 
BP, Bioprosthesis; LV,, left ventricular; MVI, mitral valve insufficiency; MVP, mitral valve prosthesis; MVS, mitral valve stenosis. For type of MVI see Table I. 
left ventricle developed 18 years after the initial 
repair in one patient. In this patient the mitral 
valve was functioning well and a cardiomyoplasty 
was performed, with a good result. Residual or 
recurrent MVI was present in 17 patients and 
mitral valve stenosis in three, but only four pa- 
tients required an early reoperation (1 to 10 days) 
after the initial repair. Among them, one patient 
died after the reoperation and is included in the 
hospital mortality statistics. Five patients in whom 
a prosthetic ring was not implanted during the 
initial operation underwent an implantation of a 
prosthetic ring during the reoperation, with a 
good result. Only three patients required a reop- 
eration for mitral valve stenosis, 14.2, 6.5, and 4 
years after the initial operation (Table VI). The 
size of the ring was 26 mm in two patients. In 
these patients an adult-sized prosthetic ring could 
be implanted after leaflet enlargement, with an 
excellent result. None of the children who under- 
went a leaflet enlargement by autologous pericar- 
dium needed a reoperation for calcification or 
retraction. 
Among the 20 patients reoperated on for mitral 
valve dysfunction, 11 had a second repair and nine 
had a valve replacement. A mechanical valve was 
used in seven and a biologic prosthesis in two. The 
latter two had yet another operation (third opera- 
tion) for degeneration of the bioprosthesis at 3.5 
and 5 years. 
Replacement group. Two patients were reoper- 
ated on for calcification of the bioprosthesis. After 
replacement with a mechanical prosthesis, both 
patients are doing well. 
Echocardiography and Doppler ultrasonography. 
Since 1980 every patients had a baseline postoper- 
ative echocardiogram. However, only 46 patients 
had a second echocardiogram at a mean of 7.5 _+ 4.3 
years after the operation (5 to 25 years). Among the 
46 patients without a valve prosthesis or reopera- 
tion, 39 had no sign of MVI at echocardiography, 
and six had grade 1/4 (trivial) regurgitation. Only 
one Md grade 3/4 MVI. ~A second repair with 
pericardial patch enlargement and prosthetic ring 
annuloplasty was possible, with a good result. One 
patient had a transmitral gradient of 18 mm Hg 
(systolic) 21 years after repair with a 32 mm pros- 
thetic ring and needs a reoperation. 
Discussion 
This is the largest series of congenital MVI with 
the longest follow-up published to date. It demon- 
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Table VII. Characteristics of the younger patients (below 2 years) 
Age Follow-up 
No. (yr) Type Operation (yr) Outcome 
1 0.6 II~ Chordal shortening 23 Doing well 
2 2 IIIA 2 Splitting 22 MVS, MVR (14 yr) 
3 1.5 II 3 Valve resection - -  Lost to follow-up at 2 mo 
4 1.5 IIj PM shortening 5 Sudden death 
5 0.8 IIIA 1 Fenestration - -  Hospital death 
6 2 IIIA2 Splitting and annuloplasty 1 MVI death 
7 1 IIl PM shortening 9.8 Doing well 
8 1.6 II 2 MVR 2.5 Death 
9 2 12 Cleft closure 10 Doing well 
10 2 IIIA 1 MVR 7.4 Doing well 
11 2 IIIA~ Commissurotomy - -  Lost to follow-up at 1 mo 
12 0.17 IIIB2 Patch + annuloplasty 4.4 Doing well 
13 1.2 12 Cleft closure 4.3 Doing well 
14 0.6 IIIA1 MVR 3.7 Doing well 
15 2 II 2 PM shortening, prosthetic ring 3.5 Doing well 
16 0.5 IIIB 2 Splitting 2.8 Reoperation at 1 day, 
patch enlargement 
17 1 I~ Semicircular annuloplasty - -  Hospital death, dilated 
cardiomyopathy 
18 0.5 Ia Semicircular annuloplasty 2.2 Doing well 
MV/, Mitral valve insufficiency; MVR, mitral valve replacement; MVS, mitral valve stenosis; PM,, papillary muscle. For type of MVI see Table I. 
strates that valve repair with Carpentier's tech- 
niques is possible in most instances and is associated 
with excellent long-term results. Of particular im- 
portance was the use, in most cases, of a prosthetic 
ring to remodel the anulus. We strongly believe that 
the concept of annular emodeling and the associ- 
ated techniques described by Carpentier were the 
key factors in the long-term stability of the results. 
Like others, we have been reluctant o use pros- 
thetic rings in children to avoid progressive stenosis 
during the child's growth. 3 However, again like 
others, we noticed a high incidence of residual or 
recurrent MVI, as high as 25% 2 when a ring was not 
used, with the exception of cases in which the MVI 
was associated with a large ventricular septal de- 
fect. 9 The importance of the prosthetic annuloplasty 
concept is accentuated in this series by five patients 
who did not receive a prosthetic ring at the first 
operation and in whom recurrent MVI developed, 
which was effectively managed by the implantation 
of a prosthetic ring during the reoperation. In this 
group the first operation was performed when the 
patients were 4.3 years (2,5 to 5 years) of age. A 
prosthetic ring could have been placed during the 
first stage. Age does not seem to be a limiting factor 
for using a prosthetic ring when the operatio n is 
performed after 2 years or 10 kg. Therefore our 
current policy to expand the use of the prosthetic 
ring and increase the use of leaflet enlargement so
that a larger prosthetic ring can be used (Fig. 5). 
Of interest, however, is that rather small rings (26 
mm or less) were associated with good long-term 
results; they were in place up to 20 years before 
becoming stenotic to the point of necessitating a 
reoperation. In these cases the stenosis was not 
due to the ring itself but rather to a fibrous 
covering of the mitral valve apparatus, which did 
not preclude a rerepair. 
An autologous pericardial patch preserved in 
glutaraldehyde remains flexible at midterm follow- 
up, 7 whereas fresh autol0gous pericardium cari;ies 
the risk of shrinkage and fibrosis. 1° 
Valve repair in children younger than 2 years of 
age remains difficult because of the very thin leaflet 
tissue encountered. Leaflet enlargement is prefera- 
ble to circular annuloplasty provided the quality of 
the valve tissue allows it, as in one of our patients 
reoperated on very early (Table VII, patient 16). 
Eighteen patients of our total cohort were 
younger than 2 years of age (Table V). Hospital 
death occurred in two of the 18 (10%) and mitral 
valve replacement was performed in three patients. 
Hospital mortality was not related to the complexity 
of the operation but rather to pulmonary hyperten- 
sion and preoperative myocardial function. Autopsy 
showed a dilated cardiomyopathy in one patient 
who was operated on at the age of 1 year for annular 
dilatation and massive cardiomegaly. Because no 
9 2 Chauvaud et al. 
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discriminative tests exist for the diagnosis of a 
primit ive cardiomyopathy (except for cardiomegaly 
present  at birth), it is difficult (o assess whether  the 
MVI  was primit ive or secondary in this patient. 
The grave prognosis in young patients has been 
under l ined in previous publications. 2' 11 However,  in 
chi ldren older than 2 years the hospital  mortal i ty is 
less than 5%. 
Certa in conclusions can be drawn from this ret- 
rospective study. Despite the complexity of the 
malformations,  12 congenital  MVI  can be effectively 
t reated by reconstructive surgery. The techniques 
descr ibed by Carpent ier  and the remodel ing annu- 
loplasty concept using suitably shaped prosthet ic 
rings were associated with the best early and long- 
term results. The use of a ring, which was thought o 
be a l imiting factor for these techniques in children, 
is largely compensated for by the quality and long- 
term stability of the result. A broader  indicat ion of 
leaflet extension increases the probabi l i ty of using 
almost adult-sized rings in most chi ldren beyond 5 
years of  age. 
We thank Dr. N. D'Attelis for his careful review of the 
manuscript and S. Romano for her skillful technical 
assistance. 
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Discussion 
Dr. Richard A. Hopkins (Providence, R.I.). Professor 
Chauvaud and colleagues under the direction of Pro- 
fessor Carpentier once again should be congratulated 
for excellent results in these 145 patients, who are truly 
children under the age of 12 years. Their mortality rates 
clearly demonstrated the long-term advantage of mitral 
valve repair over mitral valve replacement in this age 
group. 
I understand and have been indoctrinated in the func- 
tional anatomic approach by Carpentier's group, and I use 
it, but since this series specifically removed AV canal, 
corrected transposition, and straddling valves from the 
analysis, and only 20 patients were identified by diagnostic 
category, such as parachute or hammock valve, my pri- 
mary question is this: Exactly what kind of patients were 
being operated on here? 
Most of the patients appeared to have had associated 
congenital heart defects of a volume-overload type. Did 
these patients have annular dilatation and secondary 
prolapse as a consequence of volume overload, or are 
there primary congenital abnormalities within this group? 
Do the authors think that this approach is appropriate for 
the AV canal type of left AV valve that requires replace- 
ment? Do they think that in the congenitally abnormal 
mitral valve there are different roles for the secondary and 
primary chordae than in valves that were not congenitally 
abnormal? Do they think that the geometry of the mitral 
valve anulus is different in this subgroup of valves? Since 
the average ring size was 27 ram, it appears appropriate 
that techniques developed in the adult population would 
be applicable in this small adult-sized mitral anulus. 
Would the authors explain their bias for management of
children under the age of 2 years, and would they favor 
leaflet enlargement over anulus reduction in the very 
small infant? 
Dr. ~2hauvaud. Dr. Hopkins, i thank you for your 
comments. 
Regarding the dilatation of the anulus associated with 
volume overload (such as ventricular septal defect or 
other congenital anomalies), it is difficult to know exactly 
when the annular dilatation is caused by dilatation of the 
left ventricle. However, on the basis of our series these 
cases are rare, and they were associated with anomalies of 
the subvalvular apparatus. We could assume that the MVI 
per se was treated like a primary lesion and not like a 
secondary lesion. 
Regarding AV canal, we must realize that the left AV 
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valve of AV  canal defect is not a deformed mitral valve. 
As Alain Carpentier stated a long time ago, it has a very 
specific anatomy; it is not merely a cleft valve but rather a 
three-leaflet valve. In this series, we did not address the 
best way to treat annular dilatation in AV  canal defect. 
However, we do not hesitate to use a prosthetic anulus in 
children with dilatation of the anulus in the AV canal 
defect, because in our own series we observed secondary 
dilatation and reoperations necessitated by dilatation of 
the anulus. With regard to annular dilatation, we use 
exactly the same principles of valve repair in congenital 
MVI and in the AV canal defect. 
Children younger than 2 years of age are the most 
difficult to treat, and the same principles of leaflet enlarge- 
ment associated with prosthetic annuloplasty could be 
used when necessary. 
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